Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TMDX
#1134
TransMedics Group, Inc. Common Stock
145.2
6
+10.61%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+10.61%
Aylık değişim
+4.48%
6 aylık değişim
+22.71%
Yıllık değişim
+95.03%
Önceki kapanış
131.3
3
Open
145.2
6
Bid
Ask
Low
145.2
6
High
145.2
6
Hacim
83
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
TMDX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
27.18 M
27.96 M
32.2 M
32.72 M
33.66 M
34.3 M
—
Valuation ratios
Enterprise value
520.08 M
510.17 M
1.64 B
2.12 B
1.76 B
3.68 B
13.19 B
Price to earnings ratio
—
-11.97
-46.43
-99.74
61.73
24.98
189.31
Price to sales ratio
—
17.49
18.06
10.34
4.97
8.15
30.43
Price to cash flow ratio
—
-18.33
-36.84
-191.69
44.99
25.57
143.38
Price to book ratio
—
7.8
9.01
18.2
9.61
10.42
21.88
Enterprise value to EBITDA ratio
-20.97
-13.56
-58.57
-103.05
30.78
27.14
122.98
Profitability ratios
Return on assets %
0.19
0.33
0.13
0.04
0.04
0.18
0.19
Return on equity %
0.28
0.65
0.19
0.18
0.16
0.4
0.5
Return on invested capital %
671.93
483.41
306.8
66.23
43.32
21.29
23.53
Gross margin %
64.88
69.92
69.84
63.77
59.36
59.92
239.76
Operating margin %
102.91
130.29
33.64
11.89
8.49
17.93
71.79
EBITDA margin %
-96.75
-124.28
-29.92
-8.5
12.97
22.42
89.75
Net margin %
112.13
146.06
38.73
10.35
8.03
31.43
122.53
Liquidity ratios
Quick ratio
11.35
4.47
9.79
8.49
7.52
6.59
31.21
Current ratio
12.36
5.11
10.66
9.3
8.3
7.14
33.79
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.2
0.21
0.45
0.49
0.58
0.65
0.67
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.23
0.26
0.21
0.72
0.63
0.47
2.19
Long term debt to total equity ratio
0.33
0.52
0.31
3.69
2.23
1.06
6.01
Per share metrics
Operating cash flow per share
—
1.05
1.55
0.4
1.39
4.76
4.75
EBIT per share
—
-1.43
-1.06
-0.88
1.06
2.68
2.69
EBITDA per share
—
-1.36
-0.95
-0.63
1.63
3.35
3.36
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
3.35
6.81
12.14
9.56
12.05
41.13
Net current asset value per share
—
4.3
8.54
15.7
14.12
15.73
57.21
Tangible book value per share
—
2.46
6.34
3.78
6.1
11.34
33.56
Working capital per share
—
3.46
7.74
14.01
12.42
13.53
50.26
Book value per share
—
2.46
6.34
4.22
6.49
11.67
34.9
Haberler
TransMedics, 4Ç vergi avantajının kazanç etkisini açıkladı
TransMedics clarifies Q4 tax benefit impact on earnings
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
Needham, TransMedics hissesi için hedef fiyatı 174 dolara yükseltti
Needham raises TransMedics stock price target to $174 on beat
TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call Transcript
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
TransMedics güçlü sonuçlar ve rehberlikle yükseldi
TransMedics surges on earnings beat, solid guidance
Dow Jones Futures: Stock Market Bounces Before Trump Speech, Nvidia Earnings
TransMedics earnings beat by $2.23, revenue topped estimates
TransMedics’in kazancı marj soruları arasında bekleniyor